These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21818350)

  • 21. Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
    Stuurman AL; Carmona A; Biccler J; Descamps A; Levi M; Baum U; Mira-Iglesias A; Bellino S; Hoang U; de Lusignan S; Bonaiuti R; Lina B; Rizzo C; Nohynek H; Díez-Domingo J;
    Front Public Health; 2023; 11():1195409. PubMed ID: 37546295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Robison SG; Thomas AR
    Vaccine; 2018 Oct; 36(45):6683-6687. PubMed ID: 30287157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.
    Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A;
    BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.
    Rondy M; Gherasim A; Casado I; Launay O; Rizzo C; Pitigoi D; Mickiene A; Marbus SD; Machado A; Syrjänen RK; Pem-Novose I; Horváth JK; Larrauri A; Castilla J; Vanhems P; Alfonsi V; Ivanciuc AE; Kuliese M; van Gageldonk-Lafeber R; Gomez V; Ikonen N; Lovric Z; Ferenczi A; ; Moren A
    Euro Surveill; 2017 Oct; 22(41):. PubMed ID: 29043961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
    Stuurman AL; Levi M; Beutels P; Bricout H; Descamps A; Dos Santos G; McGovern I; Mira-Iglesias A; Nauta J; Torcel-Pagnon L; Biccler J;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13087. PubMed ID: 36550627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Talbot HK; Nian H; Chen Q; Zhu Y; Edwards KM; Griffin MR
    Vaccine; 2016 Apr; 34(15):1806-9. PubMed ID: 26930368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly.
    Hsu PS; Lian IB; Chao DY
    Clin Interv Aging; 2020; 15():301-312. PubMed ID: 32184579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France.
    Souty C; Vilcu AM; Capai L; van der Werf S; Valette M; Blanchon T; Lina B; Behillil S; Hanslik T; Falchi A
    J Clin Virol; 2017 Oct; 95():1-4. PubMed ID: 28818690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
    Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
    Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
    Mira-Iglesias A; López-Labrador FX; Guglieri-López B; Tortajada-Girbés M; Baselga-Moreno V; Cano L; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Díez-Domingo J; Puig-Barberà J;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada.
    Kwong JC; Chung H; Jung JK; Buchan SA; Campigotto A; Campitelli MA; Crowcroft NS; Gubbay JB; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Schwartz KL; Simor A; Smieja M; Zahariadis G;
    Euro Surveill; 2020 Jan; 25(1):. PubMed ID: 31937397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria.
    Redlberger-Fritz M; Kundi M; Popow-Kraupp T
    Front Immunol; 2020; 11():434. PubMed ID: 32256493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.
    Gilca R; Skowronski DM; Douville-Fradet M; Amini R; Boulianne N; Rouleau I; Martineau C; Charest H; De Serres G
    PLoS One; 2015; 10(7):e0132195. PubMed ID: 26200655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality.
    Savage RD; Winter AL; Rosella LC; Olsha R; Gubbay JB; Skowronski DM; Crowcroft NS
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
    Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.
    Gasparini R; Amicizia D; Lai PL; Rossi S; Panatto D
    Hum Vaccin Immunother; 2013 Jan; 9(1):144-52. PubMed ID: 23143775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics.
    Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ
    Vaccine; 2020 Jan; 38(2):318-322. PubMed ID: 31690467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.